On June 12, 2025, FibroBiologics, Inc. made changes to its bylaws, including increasing authorized capital stock and electing two new directors, Matthew Link and Victoria Niklas, M.D., at its Annual Meeting, where 54,542,916 votes were cast out of 70,498,943.